SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ann-Lii Cheng, Yoon-Koo Kang, Aiwu Ruth He, Ho Yeong Lim, Baek-Yeol Ryoo, Chao-Hung Hung, I-Shyan Sheen, Namiki Izumi, TaShara Austin, Qiang Wang, Jonathan Greenberg, Shinichi Shiratori, Robert A. Beckman, Masatoshi Kudo, Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: a phase 2 randomized study, Journal of Hepatology, 2015,

    CrossRef

  2. 2
    Rodrigo Martins Abreu, Camila Silva Ferreira, Paulo Dominguez Nasser, Luciana Oba Onishi Kikuchi, Flair José Carrilho, Suzane Kioko Ono, Hepatocellular Carcinoma: The Final Moments of Life, Journal of Cancer Therapy, 2013, 04, 02, 377

    CrossRef

  3. 3
    De-Xin Lin, Qi-Yu Zhang, Xuan Li, Qi-Wen Ye, Fen Lin, Lin-Li Li, An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus, Journal of Cancer Research and Clinical Oncology, 2011, 137, 1, 139

    CrossRef

  4. 4
    Kazuhiro Kasai, Akira Ushio, Yukiho Kasai, Kei Sawara, Yasuhiro Miyamoto, Kanta Oikawa, Hidekatsu Kuroda, Yasuhiro Takikawa, Kazuyuki Suzuki, Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma, International Journal of Clinical Oncology, 2011, 16, 3, 221

    CrossRef

  5. 5
    M. Kondo, M. Morimoto, K. Numata, A. Nozaki, K. Tanaka, Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis, Japanese Journal of Clinical Oncology, 2011, 41, 1, 69

    CrossRef

  6. 6
    Mitsuhiro Kamiyoshihara, Takashi Ibe, Izumi Takeyoshi, Hepatocellular carcinoma associated with hemorrhaging from iatrogenic rupture of a rib metastasis, General Thoracic and Cardiovascular Surgery, 2009, 57, 1, 49

    CrossRef

  7. 7
    Li-Jian Liang, Wen-Jie Hu, Xiao-Yu Yin, Qi Zhou, Bao-Gang Peng, Dong-Ming Li, Ming-De Lu, Adjuvant Intraportal Venous Chemotherapy for Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombi Following Hepatectomy Plus Portal Thrombectomy, World Journal of Surgery, 2008, 32, 4, 627

    CrossRef

  8. 8
    Robert J. Lewandowski, Joshua Tepper, Dingxin Wang, Saad Ibrahim, Frank H. Miller, Laura Kulik, Mary Mulcahy, Robert K. Ryu, Kent Sato, Andrew C. Larson, Riad Salem, Reed A. Omary, MR Imaging Perfusion Mismatch: A Technique to Verify Successful Targeting of Liver Tumors during Transcatheter Arterial Chemoembolization, Journal of Vascular and Interventional Radiology, 2008, 19, 5, 698

    CrossRef

  9. 9
    M. Ikeda, T. Okusaka, H. Ueno, C. Morizane, Y. Kojima, S. Iwasa, A. Hagihara, Predictive Factors of Outcome and Tumor Response to Systemic Chemotherapy in Patients with Metastatic Hepatocellular Carcinoma, Japanese Journal of Clinical Oncology, 2008, 38, 10, 675

    CrossRef

  10. 10
    Toru Ishikawa, Hiroteru Kamimura, Atsunori Tsuchiya, Kouji Watanabe, Keiichi Seki, Hironobu Ohta, Toshiaki Yoshida, Toshihiro Tsubono, Keiko Takeda, Noriko Ishihara, Tomoteru Kamimura, A case of advanced hepatocellular carcinoma showing marked tumor necrosis after administration of CDDP powder for intraarterial use, Kanzo, 2007, 48, 1, 27

    CrossRef

  11. 11
    Robert J. Lewandowski, Dingxin Wang, James Gehl, Bassel Atassi, Robert K. Ryu, Kent Sato, Albert A. Nemcek, Frank H. Miller, Mary F. Mulcahy, Laura Kulik, Andrew C. Larson, Riad Salem, Reed A. Omary, A Comparison of Chemoembolization Endpoints Using Angiographic versus Transcatheter Intraarterial Perfusion/MR Imaging Monitoring, Journal of Vascular and Interventional Radiology, 2007, 18, 10, 1249

    CrossRef

  12. 12
    Hiroshi Wada, Hiroaki Nagano, Takehiro Noda, Bazarragchaa Damdinsuren, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Keizo Dono, Masato Sakon, Kenichi Wakasa, Morito Monden, Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-α combination therapy following hepatic resection, Journal of Gastroenterology, 2007, 42, 6, 501

    CrossRef

  13. 13
    Soo-Jeong Cho, Jung-Hwan Yoon, Seung-Sik Hwang, Hyo-Suk Lee, Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?, Journal of Gastroenterology and Hepatology, 2007, 22, 8
  14. 14
    Toshiya Kamiyama, Kazuaki Nakanishi, Hideki Yokoo, Munenori Tahara, Takahito Nakagawa, Hirofumi Kamachi, Hiroshi Taguchi, Hiroki Shirato, Michiaki Matsushita, Satoru Todo, Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma, International Journal of Clinical Oncology, 2007, 12, 5, 363

    CrossRef

  15. 15
    A. ZIMMERMANN, Surgery of the Liver, Biliary Tract and Pancreas, 2007,

    CrossRef

  16. 16
    Iwao Ikai, Etsuro Hatano, Suguru Hasegawa, Hideaki Fujii, Kojiro Taura, Naoki Uyama, Yasuyuki Shimahara, Prognostic Index for Patients with Hepatocellular Carcinoma Combined with Tumor Thrombosis in the Major Portal Vein, Journal of the American College of Surgeons, 2006, 202, 3, 431

    CrossRef

  17. 17
    Richard B. Freeman, Transplantation for hepatocellular carcinoma: The Milan criteria and beyond, Liver Transplantation, 2006, 12, S2
  18. 18
    Masafumi Ikeda, Takuji Okusaka, Hideki Ueno, Yoriko Takezako, Chigusa Morizane, A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma, Cancer, 2005, 103, 4
  19. 19
    Timothy M. Pawlik, Ronnie T. Poon, Eddie K. Abdalla, Iwao Ikai, David M. Nagorney, Jacques Belghiti, Reza Kianmanesh, Irene Oi-Lin Ng, Steven A. Curley, Yoshio Yamaoka, Gregory Y. Lauwers, Jean-Nicolas Vauthey, Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study, Surgery, 2005, 137, 4, 403

    CrossRef

  20. 20
    Jordi Bruix, Morris Sherman, Management of hepatocellular carcinoma, Hepatology, 2005, 42, 5
  21. 21
    Nouha Dilou, Brigitte Patouillard, Jean-Christian Audigier, Les classifications de prédiction de survie du carcinome hépatocellulaire, Gastroentérologie Clinique et Biologique, 2004, 28, 4, 359

    CrossRef

  22. 22
    KAZUFUMI DOHMEN, MASAFUMI SHIRAHAMA, HIROHISA SHIGEMATSU, KOJI IRIE, HIROMI ISHIBASHI, Optimal treatment strategy for elderly patients with hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2004, 19, 8
  23. 23
    Andrew Burroughs, Daniel Hochhauser, Tim Meyer, Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum, The Lancet Oncology, 2004, 5, 7, 409

    CrossRef

  24. 24
    Junji Uraki, Koichiro Yamakado, Atsuhiro Nakatsuka, Kan Takeda, Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors, European Journal of Radiology, 2004, 51, 1, 12

    CrossRef

  25. 25
    E.A Dick, R Joarder, M de Jode, S.D Taylor-Robinson, H.C Thomas, G.R Foster, W.M.W Gedroyc, MR-guided Laser Thermal Ablation of Primary and Secondary Liver Tumours, Clinical Radiology, 2003, 58, 2, 112

    CrossRef

  26. 26
    Ziv Neeman, Steven K. Libutti, Jay W. Patti, Bradford J. Wood, Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis, Clinical Imaging, 2003, 27, 6, 417

    CrossRef

  27. 27
    Iwao Ikai, Yuzo Yamamoto, Naritaka Yamamoto, Hiroaki Terajima, Etsuro Hatano, Yasuyuki Shimahara, Yoshio Yamaoka, Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins, Surgical Oncology Clinics of North America, 2003, 12, 1, 65

    CrossRef

  28. 28
    Kyuichi Tanikawa, Chemotherapy for highly advanced hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2001, 16, 4
  29. 29
    Jordi Bruix, Morris Sherman, Josep M Llovet, Michel Beaugrand, Riccardo Lencioni, Andrew K Burroughs, Erik Christensen, Luigi Pagliaro, Massimo Colombo, Juan Rodés, Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference, Journal of Hepatology, 2001, 35, 3, 421

    CrossRef

  30. 30
    Laura Lladó, Joan Virgili, Joan Figueras, Carles Valls, Joan Dominguez, Antoni Rafecas, Jaume Torras, Joan Fabregat, Jordi Guardiola, Eduardo Jaurrieta, A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization, Cancer, 2000, 88, 1
  31. 31
    Sylvie Chevret, Jean-Claude Trinchet, Didier Mathieu, Antoine Abou Rached, Michel Beaugrand, Claude Chastang, A new prognostic classification for predicting survival in patients with hepatocellular carcinoma, Journal of Hepatology, 1999, 31, 1, 133

    CrossRef

  32. 32
    Koichiro Yamakado, Naoshi Tanaka, Atsuhiro Nakatsuka, Kaname Matsumura, Kojiro Takase, Kan Takeda, Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein, Journal of Hepatology, 1999, 30, 4, 660

    CrossRef

  33. 33
    Daniel F Schafer, Michael F Sorrell, Hepatocellular carcinoma, The Lancet, 1999, 353, 9160, 1253

    CrossRef

  34. 34
    Josep M. Llovet, Javier Bustamante, Antoni Castells, Ramon Vilana, Maria Del Carmen Ayuso, Margarita Sala, Concepció Brú, Joan Rodés, Jordi Bruix, Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials, Hepatology, 1999, 29, 1
  35. 35
    Iwao Ikai, Yoshio Yamaoka, Yuzo Yamamoto, Nobuhiro Ozaki, Yoshiharu Sakai, Seiji Satoh, Niobuhiko Shinkura, Masayuki Yamamoto, Surgical Intervention for Patients With Stage IV-A Hepatocellular Carcinoma Without Lymph Node Metastasis, Annals of Surgery, 1998, 227, 3, 433

    CrossRef

  36. 36
    Nan-Haw Chow, Ping-I Hsu, Xi-Zhang Lin, Hsiao-Bai Yang, Shih-Huang Chan, Kuo-Sheng Cheng, Shih-Ming Huang, Ih-Jen Su, Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: An immunohistochemical study, Human Pathology, 1997, 28, 6, 698

    CrossRef

  37. 37
    H. Nagahama, S. Okada, T. Okusaka, H. Ishii, M. Ikeda, H. Nakasuka, M. Yoshimori, Predictive Factors for Tumor Response to Systemic Chemotherapy in Patients With Hepatocellular Carcinoma, Japanese Journal of Clinical Oncology, 1997, 27, 5, 321

    CrossRef

  38. 38
    Keith E. Stuart, Ajay J. Anand, Roger L. Jenkins, Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival, Cancer, 1996, 77, 11
  39. 39
    Irene O.L. Ng, Matthew M.T. Ng, Edward C.S. Lai, Sheung T. Fan, Pathologic features and patient survival in hepatocellular carcinoma in relation to age, Journal of Surgical Oncology, 1996, 61, 2
  40. 40
    Luca Mondazzi, Riccardo Bottelli, Giorgio Brambilla, Antonio Rampoldi, Indira Rezakovic, Claudio Zavaglia, Alberto Alberti, Gaetano Idèo, Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors, Hepatology, 1994, 19, 5
  41. 41
    Amin A. Nanji, Shuping Zhao, Robert G. Lamb, S. M. Hossein Sadrzadeh, Andrew J. Dannenberg, David J. Waxman, Changes in Microsomal Phospholipases and Arachidonic Acid in Experimental Alcoholic Liver Injury: Relationship to Cytochrome P-450 2E1 Induction and Conjugated Diene Formation, Alcoholism: Clinical and Experimental Research, 1993, 17, 3